Related Experiment Videos
LAP negative and Ph1-positive hemorrhagic thrombocythemia
Medecine Interne
|January 1, 1977
Summary
This study examined four patients with chronic myeloproliferative disorders, noting partial adherence to hemorrhagic thrombocythemia criteria. The presence of the Philadelphia chromosome (Ph1) and low leukocyte alkaline phosphatase (LAP) levels were key findings.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Chronic myeloproliferative disorders (MPDs) represent a group of clonal hematopoietic stem cell malignancies.
- Distinguishing between MPDs, such as hemorrhagic thrombocythemia (HT), can be challenging due to overlapping clinical and hematological features.
Observation:
- Cytochemical and cytogenetic analyses were performed on four patients presenting with MPDs.
- These patients exhibited features partially consistent with hemorrhagic thrombocythemia (HT).
- Key observations included low leukocyte alkaline phosphatase (LAP) levels and the presence of the Philadelphia chromosome (Ph1) in 46, XX mitoses.
Findings:
- The presence of the Philadelphia chromosome (Ph1) was identified in all analyzed cases.
- Low LAP scores were consistently observed in these patients.
- The findings suggest a potential overlap or transitional state between different MPD classifications.
Implications:
- The Philadelphia chromosome (Ph1) may be a significant indicator in MPDs, even when clinical criteria are not fully met.
- These cases highlight the complexity of MPD classification and the potential for transition forms.
- Further research is warranted to elucidate the prognostic and diagnostic significance of Ph1 in atypical MPD presentations.